Humalog Mix 75/25

   
Google
 
Web NewDrugInformation.com

Humalog Mix 75/25


Drug - Humalog Mix 75/25
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Insulin Lispro Protamine Recombinant; Insulin Lispro Recombinant
Multiple ingredients are in alphabetical order.

Strength - 75 UNITS/ML;25 UNITS/ML
The potency of the active ingredient(s), Insulin Lispro Protamine Recombinant; Insulin Lispro Recombinant. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Humalog Mix 75/25. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021017
The FDA assigned number to Humalog Mix 75/25. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Humalog Mix 75/25. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 22, 1999
The date Humalog Mix 75/25 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Humalog Mix 75/25. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Humalog Mix 75/25 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Humalog Mix 75/25.

Humalog Mix 75/25